Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Cell & Gene Therapy Manufacturing Services Industry By The Forecast Year 2029?
The cell & gene therapy manufacturing services market size has seen rapid expansion in recent years. It is projected to grow from $8.15 billion in 2024 to $9.44 billion in 2025, at a compound annual growth rate (CAGR) of 15.9%. This historical growth can be attributed to several factors including increased R&D investments, supportive regulatory frameworks, an expanding pipeline of cell & gene therapies, various industry collaborations and partnerships, and the escalating global demand for personalized medicine.
The cell & gene therapy manufacturing services market size is anticipated to experience significant expansion in the coming years. It is projected to increase to $17.92 billion by 2029, achieving a compound annual growth rate (CAGR) of 17.4%. The growth during this forecast period can be attributed to factors like market maturation and commercialization, the global expansion of biopharmaceutical manufacturing, increased outsourcing by pharmaceutical companies, advancements in automation and robotics, and the emergence of new therapeutic modalities. Key trends influencing this period include a rising demand for energy efficiency, the adoption of advanced materials and technologies, the development of compact and modular designs, the electrification of transportation, and a strong focus on safety and reliability.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Which Major Market Drivers Are Shaping The Future Of The Cell & Gene Therapy Manufacturing Services Market?
A significant occurrence of cancer and related illnesses is anticipated to boost the expansion of the cell and gene therapy manufacturing services market in the future. Cancer refers to a serious condition characterized by the rapid and unrestrained multiplication of the body’s cells, leading to irregular tissue development. As effective new approaches to tackle the increasing prevalence of cancer, cell and gene therapies are emerging, thereby fueling the need for innovative and effective therapeutic options. For example, data from January 2023, provided by the American Cancer Society, a US-based nonprofit cancer advocacy organization, shows an escalation in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, representing a 3.16% rise. Consequently, the elevated occurrence of cancer and other target diseases is stimulating the expansion of the cell and gene therapy manufacturing services market moving ahead.
Which Key Segments Fueling The Cell & Gene Therapy Manufacturing Services Market?
The cell & gene therapy manufacturing servicesmarket covered in this report is segmented –
1) By Type: Gene Therapy; Cell Therapy
2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
3) By Application: Commercial Manufacturing; Clinical Manufacturing
4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing; Plasmid DNA Production; Gene Editing Services; Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking; Cell Processing And Expansion; Quality Control And Testing Services; Cryopreservation And Storage Services
How Are Emerging Market Trends Shaping The Cell & Gene Therapy Manufacturing Services Industry Landscape?
Technological advancements are emerging as a significant trend within the cell and gene therapy manufacturing services market. Leading companies operating in this sector are incorporating novel technologies to maintain their standing. As an illustration, in October 2022, Charles River Laboratories International Inc., a US-based pharmaceutical entity known for its preclinical and clinical laboratory, gene therapy, and cell therapy services, introduced its navigation Vector Platform (navigation). This platform simplifies the path to GMP Adeno-Associated Virus (AAV) vector manufacturing, eliminating the need for extensive process development. Compared to conventional manufacturing workflows, the navigation platform can reduce a program’s timeframe to GMP by 55% for viral vector gene therapy researchers. Charles River’s navigation technique is based on a distinctive high-productivity HEK293 suspension cell line, which can be scaled up and serotyped to meet specific client requirements.
Which Global Market Leaders Are Shaping The Future Of The Cell & Gene Therapy Manufacturing Services Sector?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Cell & Gene Therapy Manufacturing Services Industry Expansion?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Cell & Gene Therapy Manufacturing Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Browse Through More Reports Similar to the Global Cell & Gene Therapy Manufacturing Services Market 2025, By The Business Research Company
Covid 19 Detection Test Kits And Consumables Global Market Report 2025
Covid 19 Rapid Test Kits Market 2025
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Central Lab Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/central-lab-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model